StonvexLoading…
StonvexStonvexStonvexCore line items from DBVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $900.00K | $5.64M | $4.99M | $2.22M |
Operating Income | $-47.90M | $-147.06M | $-102.00M | $-67.73M |
Net Income | $-47.60M | $-146.95M | $-102.12M | $-41.88M |
EPS (Diluted) | $-0.11 | $-1.05 | $-0.82 | $-0.58 |
Total Assets | $266.40M | $233.70M | $110.50M | $143.43M |
Total Liabilities | $58.40M | $64.90M | $57.64M | $57.20M |
Cash & Equivalents | $229.20M | $194.20M | $69.84M | $103.21M |
Free Cash Flow OCF − CapEx | $-49.50M | $-121.71M | $-86.17M | $-53.62M |
Shares Outstanding | 428.30M | 139.57M | 136.98M | 136.97M |